Abstract P096 Table 1

Efficacy modified Raymond Roy Occlusion Classification (mRROC)

mRROCeBRS (n = 19)
Median followup 37 mo (range 9 – 69 mo)
eB (n = 13)
Median followup 10 mo (range 8 – 32 mo)
1 16 (84%) 13 (100%)
2 2 (11%) 0
3A 1 (5%) 0
3B 0 0